Connecticut 2025 2025 Regular Session

Connecticut Senate Bill SB01507 Introduced / Fiscal Note

Filed 04/09/2025

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
sSB-1507 
AN ACT PROHIBITING PRIVATE EQUITY OWNERSHIP AND 
CONTROL OF HOSPITALS AND HEALTH SYSTEMS AND THE 
CONTROLLING OF OR INTERFERENCE WITH THE 
PROFESSIONAL JUDGMENT AND CLINICAL DECISIONS OF 
CERTAIN HEALTH CARE PROVIDERS AND REQUIRING AN 
EVALUATION OF THE APPOINTMENT OF A RECEIVER TO 
MANAGE HOSPITALS IN FINAN CIAL DISTRESS.  
 
Primary Analyst: NB 	4/8/25 
Contributing Analyst(s):    
Reviewer: JS 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 26 $ FY 27 $ 
Public Health, Dept. GF - Cost 121,300 153,500 
State Comptroller - Fringe 
Benefits
1
 
GF - Cost 42,700 58,400 
Note: GF=General Fund 
  
Municipal Impact: None  
Explanation 
This bill, which includes various provisions regarding hospitals, 
health systems, and health care practices, results in a cost to the General 
Fund of $164,000 in FY 26 and $211,900 in FY 27 and annually thereafter, 
as described below.  The cost is associated with personnel needs in the 
Department of Public Health (DPH) due to Section 2. 
Section 1 prohibits private equity companies and real estate 
investment trusts from new or increased acquisitions or control of any 
                                                
1
The fringe benefit costs for most state employees are budgeted centrally in accounts 
administered by the Comptroller. The estimated active employee fringe benefit cost 
associated with most personnel changes is 40.71% of payroll in FY 26.  2025SB-01507-R000614-FN.DOCX 	Page 2 of 3 
 
 
hospital or health system, which results in no fiscal impact to the state. 
Section 2 prohibits licensed health care entities and management 
services organizations from controlling clinical decisions of a health care 
practice or clinician. This results in a cost to DPH of $121,300 in FY 26 
and $153,500 in FY 27 (and annually thereafter), with an estimated cost 
to the Office of the State Comptroller for associated fringe benefits of 
$42,700 in FY 26 and $58,400 in FY 27.  FY 26 costs reflect an October 1 
start date for all staff. 
It is anticipated that this prohibition will result in an increase in case 
volume for the Facility Licensing and Investigations Section (FLIS) 
regarding interference and coercion claims. To handle this increase, 
DPH requires: (1) a part-time (0.5 FTE) Supervising Nurse Consultant, 
at an annualized salary of $47,500 (plus $19,300 annualized fringe 
benefits); and (2) a full-time Nurse Consultant investigator, at an 
annualized cost of $96,000 (plus $39,100 annualized fringe benefits). 
These positions will complete essential duties in conducting healthcare 
investigations, such as reviewing patient records and facility 
documentation as well as interviewing staff and patients. The FLIS 
currently has a backlog of approximately 1,000 complaints, making 
additional staff necessary to complete investigative work that may 
result from this bill. 
Other expenses are expected to total $16,500 in FY 26 and $10,000 in 
FY 27 in annually and thereafter.  This includes a one-time total cost of 
$8,400 in FY 26 for laptops and related hardware, and ongoing annual 
costs of $10,000 (with partial year costs in FY 26 of $8,100) consisting of: 
(1) fleet maintenance costs for one motor vehicle ($4,600) needed to 
allow investigations to be conducted at facilities across the state; (2) 
mileage reimbursement ($5,000); and (3) $400 for software and general 
office supplies. 
Section 3 requires the Commissioner of Health Strategy to evaluate 
the potential appointment of a receiver to manage hospitals in financial 
distress or operational crisis, which results in no fiscal impact. The 
duties required by the bill can be accomplished through existing  2025SB-01507-R000614-FN.DOCX 	Page 3 of 3 
 
 
resources. 
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to inflation.